Overview
- 60 inspections across 56 sites are on record.
- 187 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-10.
At a glance
Inspections
60
Sites
56
Observations
187
Career since
Oct 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Medtronic, Inc. | 10 Dec 2025 | Human Drugs | On file |
| Grand River Aseptic Manufacturing, Inc. | 4 Nov 2025 | Human Drugs | On file |
| Grand River Aseptic Manufacturing Inc. | 4 Nov 2025 | Human Drugs | View 483 → |
| Par Health USA, LLC | 20 Oct 2025 | Human Drugs | On file |
| Eli Lilly and Company | 11 Sep 2025 | Human Drugs | On file |
Sites inspected
Medtronic, Inc.Minneapolis, United States1 insp.
Grand River Aseptic Manufacturing, Inc.Grand Rapids, United States1 insp.
Grand River Aseptic Manufacturing Inc.Caledonia, United States1 insp.
Par Health USA, LLCRochester, United States1 insp.
Eli Lilly and CompanyPleasant Prairie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Joohi Castelvetere8 shared
Alan M Barker4 shared
Anna M Spiros3 shared
Monica E Murie3 shared
Nicholas J Presto3 shared
Michele Perry-Williams3 shared
Brent M Dehaan3 shared
Gavin T Cua3 shared
Charles L Zhou3 shared
Shannon L Maisano2 shared
Full investigator report
Get the verbatim findings behind Jacob G Lutz's 187 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site